| 股票代码 | 股票名称 | 持有份额(万股) | 仓位比例 | 涨跌 | 贡献增长率 |
| 600521 | 华海药业 | 0.0000 | 5.25% | 0.96% | 0.0504% |
| 603939 | 益丰药房 | 0.0000 | 4.52% | 1.88% | 0.0850% |
| 300181 | 佐力药业 | 0.0000 | 4.47% | -1.48% | -0.0662% |
| 603301 | 振德医疗 | 0.0000 | 4.44% | 1.26% | 0.0559% |
| 688278 | 特宝生物 | 0.0000 | 4.36% | -0.61% | -0.0266% |
| 300633 | 开立医疗 | 0.0000 | 4.15% | 8.15% | 0.3382% |
| 603233 | 大参林 | 0.0000 | 4.10% | 3.82% | 0.1566% |
| 688677 | 海泰新光 | 0.0000 | 4.05% | 3.49% | 0.1413% |
| 605507 | 国邦医药 | 0.0000 | 3.74% | -1.48% | -0.0554% |
| 301033 | 迈普医学 | 0.0000 | 3.02% | 1.00% | 0.0302% |
| 重仓股仓位合计 | 重仓股贡献增长率 | 总持股仓位 | 修正增长率 | ||
| 42.1% | 0.7094% | 89.58% | |||
| 日期 | 实际增长率 | 预估增长率 |
| 2025-02-07 | 0.70% | 0.74% |
| 2025-02-06 | 0.21% | 0.17% |
| 2025-02-05 | -0.69% | -0.47% |
| 2025-01-27 | 0.37% | 0.14% |
| 2025-01-22 | -0.74% | -0.56% |
| 2025-01-14 | 1.92% | 2.56% |
| 2025-01-13 | -0.44% | -0.16% |
| 2025-01-10 | -1.13% | -1.72% |
| 基金名称 | 单位净值 | 日增长率 |
| 信达消费 | 1.2981 | 1.5752% |
| 信达澳银至诚精选混合 | 0.4598 | 1.5624% |
| 澳银产业 | 1.4441 | 1.2004% |
| 信达澳银优势价值混合A | 0.7326 | 1.1103% |
| 信达澳银优势价值混合C | 0.7154 | 1.1103% |
| 信达中小盘 | 1.3474 | 1.0769% |
| 信达澳银价值精选混合A | 0.7392 | 0.8782% |
| 信达澳银价值精选混合C | 0.7212 | 0.8782% |
